Lindbrook Capital LLC Lowers Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Lindbrook Capital LLC trimmed its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 15.4% during the third quarter, Holdings Channel.com reports. The fund owned 1,345 shares of the medical equipment provider’s stock after selling 245 shares during the quarter. Lindbrook Capital LLC’s holdings in Intuitive Surgical were worth $661,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Creekmur Asset Management LLC lifted its holdings in Intuitive Surgical by 200.0% during the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 42 shares during the period. Ridgewood Investments LLC purchased a new stake in shares of Intuitive Surgical during the 2nd quarter valued at $26,000. Delos Wealth Advisors LLC raised its stake in shares of Intuitive Surgical by 380.0% during the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 57 shares during the period. Godsey & Gibb Inc. raised its stake in shares of Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares during the period. Finally, LRI Investments LLC purchased a new position in shares of Intuitive Surgical in the 1st quarter worth about $30,000. Institutional investors own 83.64% of the company’s stock.

Analysts Set New Price Targets

ISRG has been the topic of several research reports. Truist Financial lifted their price objective on shares of Intuitive Surgical from $520.00 to $570.00 and gave the stock a “buy” rating in a research report on Monday, October 14th. Morgan Stanley upped their price objective on Intuitive Surgical from $375.00 to $460.00 and gave the company an “equal weight” rating in a research note on Monday, July 15th. BTIG Research set a $535.00 target price on Intuitive Surgical in a research report on Friday, October 18th. Raymond James upped their price target on Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a research report on Monday, October 14th. Finally, Piper Sandler restated an “overweight” rating and issued a $538.00 price objective (up from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. One analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have given a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $513.74.

Insider Buying and Selling

In other Intuitive Surgical news, SVP Henry L. Charlton sold 40,243 shares of the business’s stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $486.84, for a total value of $19,591,902.12. Following the completion of the transaction, the senior vice president now owns 3,001 shares of the company’s stock, valued at $1,461,006.84. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, SVP Henry L. Charlton sold 40,243 shares of the firm’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the sale, the senior vice president now owns 3,001 shares in the company, valued at approximately $1,461,006.84. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Robert Desantis sold 188 shares of the company’s stock in a transaction on Thursday, August 29th. The stock was sold at an average price of $482.21, for a total transaction of $90,655.48. Following the completion of the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,655,048.26. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 68,246 shares of company stock worth $33,839,308. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $536.45 on Friday. The company has a market cap of $191.07 billion, a price-to-earnings ratio of 86.25, a PEG ratio of 5.07 and a beta of 1.39. Intuitive Surgical, Inc. has a one year low of $269.49 and a one year high of $538.49. The firm has a fifty day moving average price of $493.92 and a two-hundred day moving average price of $451.73.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.24 by $0.32. The company had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. Equities research analysts expect that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.